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abstract
Objective: To evaluate the costs of a topical treatment of pressure ulcer (PU) patients in a 
hospital unit for treatment of chronic patients in 2014. Method: This is an activity-based 
costing study. This method encompasses the identification, measurement and pricing of 
physical and human resources consumed for dressings. Results: Procedure costs varied 
between BRL 16.41 and BRL 260.18. For PUs of the same category, of near areas and 
with the same type of barrier/adjuvant, the cost varied between 3.5% and 614.6%. For 
most dressings, the cost increased proportionally to the increase of the area and to the 
development of PU category. The primary barrier accounted for a high percentage of costs 
among all items required to the application of dressings (human and material resources). 
Dressings applied in sacral PUs had longer application times. Conclusion: This study 
allowed us to understand the costs involved in the treatment of PUs, and it may support 
decision-makers and other cost-effectiveness studies.
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INTRODUCTION
Skin changes are one of the most common consequenc-
es of long periods of hospitalization. Among these changes, 
pressure ulcers (PU) are the ones with the greatest impact, 
for both patients and their relatives and the health system, 
since they involve longer hospital stays, a risk of infections 
and other complications(1), in addition to high costs.
The WOCN (Wound, Ostomy and Continence Nurses 
Society) considers that most PUs can be avoided by means 
of preventive measures(2). If the PU occurs despite the 
implementation of these measures, we can say that it was 
inevitable and did not happen as a result of care negligence, 
but rather because of its multiple causes(3). This fact en-
couraged Medicare (American health insurance system) to 
refuse reimbursement of costs related to hospital-acquired 
PUs since 2008(4).
Although the evolution of health care is continuous, the 
occurrence of PUs remains high, especially in hospitalized 
patients(5). In the international setting, the prevalence varies 
between 5.0 and 15%, and the incidence between 1.9 and 
7%(3,6-9). International studies show a prevalence of 11.1 to 
23.2%, and an incidence of 22.5 to 66.6%(10-14).
Costs of PU management represent a constant chal-
lenge for health institutions, since the economic aspect is 
essential for making decisions related to the use of tech-
nologies(15). The use of different barriers for treating PUs 
is common, although there is not a broad discussion con-
cerning the comparative efficiency/effectiveness and costs 
related to treatment. There are few studies available in the 
literature that measure the economic impact of this dis-
ease, and these studies have countless limitations regarding 
their generalization(16).
In the United Kingdom, it was estimated that 412 thou-
sand people develop a new PU every year and that the cost 
variation for PU healing is GBP 1.064 (Category I) up to 
GBP 10.551 (Category IV)(17). In Portugal, EUR 9 million 
were allocated to PU treatment in Macaronesia (Azores, 
Madeira, Canary and Cape Verde archipelagos) in 2006. 
This cost corresponded to 4.5% of the public spending on 
health in Azores and 0.3% of its GDP that year(18). Another 
study carried out in Ireland that evaluated the cost of PU 
in category IV showed that EUR 119 thousand per patient 
are spent over a period of five months. In this same study, 
the authors stated that EUR 250 million are spent every 
year to manage PUs in all places of care in Ireland(19). In 
Brazil, eight studies on PU costs were found. In the first 
one, the average cost per patient varied between BRL 98.90 
and BRL 180.00 per day, and it increased proportionally to 
the increase of the extent of tissue destruction(15). The sec-
ond, carried out in Minas Gerais, found a monthly spend-
ing that varied between BRL 915.75 and BRL 36,629.95. 
The estimated annual costs were BRL 445,664.38, exclud-
ing spendings with human and physical resources (such as 
water, electricity, telephone and others)(20).
Given the high costs involved, cost studies are relevant 
to support professionals in the development of strategies for 
the management of PUs(19). In that sense, the objective of 
this study was to evaluate the costs of a topical treatment of 
pressure ulcer (PU) patients in a hospital unit for the treat-
ment of chronic patients in 2014.
METHOD
This is a cost study developed in a hospital unit of the 
Minas Gerais Hospital Foundation (FHEMIG, as per its 
acronym in Portuguese), which is responsible for care of 
patients who are mostly victims of trauma and who need 
long-term hospitalizations. We included in the study PUs 
of adult patients who had been hospitalized for more than 
24 hours. Data were collected by a researcher, between June 
and December 2014.
The cost study was composed of five stages, as defined by 
the ABC methodology (Activity-Based Costing)(21):
I. Identification and definition of macroprocesses, pro-
cesses and activities related to PUs;
II. Creation of mapping of typical processes of patients 
who suffer from PU;
III. Identification of resources used in each activity, such 
as time spent with each activity, medical-hospital equip-
ment and human resources;
IV. Construction of a database connected with the 
Hospital Management Integrated System (SIGH) linked 
with the ABC of FHEMIG, which consists of valuating the 
whole process according to the costs reported by FHEMIG;
V. Study validation by a board of experts.
The cost measurement methodology was based on the 
Activity-based costing – ABC, which seeks a more organic 
vision of the institution at the origin and pricing of events, 
procedures, packages, resources, allocations, transactions, 
and especially processes by means of a systemic view(21). 
This methodology was previously applied to describe the 
costing of procedures and services, with the aim to ground 
the institution’s managing development(22).
The process design (stage I) followed the interview 
model based on the method proposed by Gonçalves and 
Meireles (2004)(23) of critical success factors (Rockart). The 
interviews were conducted in the place of study, i.e. the hos-
pital, with two nurses of the commission of prevention and 
treatment of injuries, and they included two phases: survey 
and confirmation.
In the stage of mapping typical processes (stage II), the 
application of 26 dressings by two nurses of the aforemen-
tioned commission were mapped on-site. Of these dress-
ings, four corresponded to PU category II; one to category 
III; 13 to category IV and six to PUs that could not be 
classified. The number of mapped dressings was defined by 
data saturation, that is, time spent and the amount of inputs 
consumed to perform each activity began to present similar 
or approximate figures after the 26 dressings were mapped. 
During that stage, all inputs consumed in the process ac-
tivities (dressing) were reported: medication (saline solu-
tion at 0.9%), medical-hospital equipment (such as needles, 
syringes, gloves, gauze compresses of 7.5 x 7.5 cm²) and 
human resources (nursing professionals).
In the definition of activities that are part of the pro-
cesses, drivers were established so as to adapt resources to 
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activities (Stage III). The activity drivers tracked the activ-
ity costs to the object of cost, thus allowing for a higher 
degree of certainty regarding its effectiveness in the activity 
allocation. To define these drivers, each resource was ana-
lyzed, and also the activities in which these resources were 
used. To identify the workforce, time spent (in minutes) was 
found for each activity, and to allocate consumable material, 
a direct identification of the amount used was performed 
(medication and medical equipment).
Stage IV consisted of the use of FHEMIG’s SIGH-
Costs to build the database, under direct allocation, tracking 
and distribution. Constitutive activity resources and costs 
were measured (stage V).
Personnel costs were obtained by means of information 
generated by SIGH-Costs. Data were based on the payroll 
of all employees involved by means of the Employees Time 
Clock System (SAPT, as per its acronym in Portuguese). 
Costs with consumable materials were obtained by means 
of reports from the storage of the Material Management 
Integrated System (SIAD), in addition to those generated 
by SIGH-Costs. The consumable materials group was in 
turn divided into medical-hospital materials, medication 
and barrier/adjuvants.
This study addresses the Unified Health System ap-
proach. Since the range of time variation and use of materi-
als is wide, data were reported according to their minimum 
and maximum values. Therefore, it was possible to define a 
range of values in which each procedure had to be included. 
The values are expressed in local currency (Brazilian Real) 
for the year 2014.
This study complied with rules set out in Resolution 
466, of December 2012, by the National Health Council 
for human research(24). Interviews and procedures carried 
out by professionals regarding stages I and II of the ABC 
were monitored by the main researcher, after the Free and 
Informed Consent Form was signed by members of the 
nursing staff. The study was approved by the Research 
Ethics Committee under number 31711014.5.3001.5119.
For the purpose of understanding the terms used in this 
article, some definitions follow: Barriers are all material, sub-
stance or product applied on the wound which forms a phys-
ical barrier that is able to cover and protect the wound bed(25). 
It is called primary when it is applied directly on the wound 
bed and/or surrounding skin, and secondary when placed 
onto a primary dressing. Adjuvants are auxiliary products 
used together with barriers or as a complement to wound 
healing. And Category refers to the translation of the classi-
fication used by the National Pressure Ulcer Advisory Panel 
(NPUAP)(26), which assesses the severity of PUs according 
to the loss and anatomical depth of the wounded tissue(27).
RESULTS
In stage I of the ABC methodology, the procedure PU 
dressing was mapped and resulted in a flowchart of the con-
stitutive stages of the process (Figure 1).
Start
Perform cleaning of the
PU with jets of saline
solution at 0.9%
Dry the PU edges
Evaluate the kind(s) of tissue
present in the wound bed
Measure the size, depth
and overlapping
Evaluate the wound
edges as to the
presence of maceration
and evenness
Assess the quantity
and characteristic of
the exudate
Apply primary barrier
Apply secondary barrier
Date and sign the
dressing and identify the
barrier used
Communicate the patient
about the procedure to be
carried out
Position the patient
Remove secondary
barrier
Saturated primary
barrier?
No
Yes
Instrumental
debridement
No
Yes
Does it have a delimited
necrotic tissue?
Remove primary barrier
Figure 1 – Flowchart of the constitutive stages of the application process of a dressing in a public hospital of Minas Gerais – Belo 
Horizonte, MG, Brazil, 2014.
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The minimum and maximum costs were described ac-
cording to PU category of barrier/adjuvants used for dress-
ings and PU area (Table 1). For category II, smaller sized 
areas (5-8 cm2) had costs which ranged from BRL 67.69 to 
BRL 92.08; whereas larger areas (25-32 cm2) costs ranged 
from BRL 67.89 to BRL 172.32. The maximum cost varied 
up to 154.6% compared to the minimum cost for the same 
barrier (hydrocolloid) of different sizes.
For category III PUs, dressings applied with alginate 
had a variation between minimum and maximum costs of 
76.1% Due to the impossibility of grouping the only PU in 
category III with the others done with hydrogel adjuvant, 
its cost was expressed in one single value.
For category IV PUs, it was seen that hydrofiber and sil-
ver dressings had minimum and maximum costs that varied 
112.3% (from BRL 89.59 to BRL 190.24). With the hydro-
gel barrier, the variation was 3.5%. The variation observed 
between the minimum (BRL 20.04) and maximum (BRL 
143.21) costs with alginate barrier was significant (614.6%). 
The difference between the costs of collagen and alginate 
was 67.8%.
For PUs that could not be classified, it was found that 
the minimum cost of dressings done with hydrogel var-
ied up to 525.10% (BRL 16.41 to BRL 102.58) for dif-
ferent sizes. The cost variation with nanocrystalline silver 
was 35.1%.
Table 1 – Costs (minimum and maximum) according to the PU category, barrier/adjuvant used and PU area in a public hospital of 
Minas Gerais – Belo Horizonte, MG, Brazil, 2014.
categories Primary barrier/adjuvant PU area (cm²) Minimum cost (brl) Maximum cost (brl)
II Hydrocolloid
5cm² to 8cm² 67.69 92.08
25cm² to 32cm² 67.89 172.32
III
Alginate 87.5cm² to 130cm² 29.02 51.10
Hydrogel 52.5cm² 96.38
IV
Hydrofiber and silver
Up to 55cm² 93.31 133.71
99cm² to 120cm² 89.59 190.24
Hydrogel 190cm² to 234cm² 129.27 133.78
Alginate 37.5cm² to 42.5cm² 20.04 143.21
Collagen and alginate 98cm² to 102cm² 134.29 225.34
Could not be 
classified
Hydrogel
45.5cm² 28.20 51.59
21cm² to 24.5cm² 16.41 102.58
Nanocrystalline silver 96cm² to 120.5cm² 192.64 260.18
Of dressings that needed a secondary barrier, the pri-
mary barrier accounted for a greater percentage of costs, 
except for those in which hydrogel and alginate were used, 
and which the secondary barrier (hydrocolloid) and acrylic 
copolymer spray (Cavilon spray®) were used.
Considering the price per unit of barrier/adjuvant in re-
lation with the total cost of PU treatment (human resources 
and medical-hospital material), it is seen that the variation 
ranges from 4.9% to 96.7% (Table 2). The barrier with the 
lowest cost per unit is alginate (BRL 7.02) and those with 
the highest costs are collagen with alginate (BRL 129.00) 
and nanocrystalline silver (BRL 160.00). The price of bar-
riers in relation with the total cost varied between 4.9 and 
35%, 57.2 and 96.1% and 61.5 and 83.1%, respectively. The 
price of calcium alginate accounted for a lower percentage 
in relation with total costs (4.9 to 35.0%). As for the price 
of hydrocolloid, it accounted for a higher percentage in rela-
tion with total costs (38.0 to 96.7%).
Table 2 – Price per unit of barriers/adjuvants and percentage of barrier price in relation with total cost in a public hospital of Minas 
Gerais – Belo Horizonte, MG, Brazil, 2014.
barrier/adjuvant Unit price (brl)a
Percentage of (a) in relation with total costs (%)
Minimum Maximum
Calcium alginate 7.02 35.0 4.9
Hydrogel 13.5 82.3 10.1
Hydrocolloid 65.48 96.7 38.0
Hydrofiber and silver 65.48 73.1 34.4
Collagen and alginate 129.00 96.1 57.2
Nanocrystalline silver 160.00 83.1 61.5
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Table 3 presents the minimum and maximum times 
spent to apply dressings, according to the PU location. 
Dressings applied in intravertebral PUs were applied more 
quickly (5.8 to 10.7’), whereas sacral PUs took the longest 
to apply (14.8 to 33.7’).
Table 3 – Minimum and maximum times to apply dressings, ac-
cording to the PU anatomical location in a public hospital of 
Minas Gerais – Belo Horizonte, MG, Brazil, 2014.
anatomical location Minimum time(minutes)
Maximum time
(minutes)
Intraparavertebral 5.8 10.7
Shoulder 7.9 8.8
Trochanteric 8.7 21.7
Sacral 14.8 33.7
DISCUSSION
Pressure ulcers are a serious public health issue, both 
for being often avoidable and the high costs related to their 
management. In this study, a wide variation of costs of pri-
mary barriers and adjuvants was observed in PU treatment. 
Considering the costs with barriers, medical-hospital ma-
terial and human resources, they ranged from BRL 16.41 
to BRL 260.18, depending on the type of barrier and PU 
size. The cost variation within the same category and type 
of barrier was large, from 3.5% to 614.6%.
For most dressings, the cost increased proportionally 
to the increase of the area and to the development of PU 
category. Studies carried out in 2004 and 2013 also showed 
a cost increase according to the PU category(15,17). Larger 
areas clearly need more material resources and require more 
time for execution. Dressing costs are occasional measure-
ments, and the variation according to the PU category could 
be better observed if spendings on PU treatment were ac-
counted for from its outbreak until its healing, as time for 
healing tends to be longer for more severe PUs.
The primary barrier accounted for a high percentage of 
costs among all items required to the application of dress-
ings (human and material resources), except for those in 
which hydrogel and calcium alginate were used. In that 
sense, cost comparisons are important since unit prices of 
barriers alone are not the best savings indicator in the con-
sumption of resources. In addition to this, efficiency/effec-
tiveness evaluations of these technologies must be carried 
out to assess the procedure efficiency.
In the unit where this study was carried out, all hydrocol-
loid plates used for dressings were 15cm x 15cm²; however, 
in some cases, the whole plate was not used. The remaining 
hydrocolloid plate was left in patients’ compartments in or-
der to be used afterwards. However, it was noticed that ste-
rility control and maintenance could be affected. This could 
have an influence on cost increase, in addition to impair 
patients’ safety. Therefore, it is the institution’s responsibility 
to provide different sizes of barrier/adjuvants, and it is up to 
nurses to anticipate the size of the adequate barrier for the 
PU location and/or depth. While the 15x15cm² hydrocol-
loid plate costs BRL 65.48, the 10x10 one costs only BRL 
16.00. For dressings described in this study and done with 
hydrocolloid, the 10x10 plate would fit well, considering 
PU areas.
The 15x15cm² hydrocolloid plate (BRL 65.48 per unit), 
used as a secondary barrier, was the input that most in-
creased the costs of dressings done with calcium alginate 
as a primary barrier. As this barrier and the hydrocolloid 
belong to different categories, with different mechanisms of 
action as well, the best option would be a different second-
ary barrier, such as the 10x12cm² transparent film, which 
costs BRL 10.00. In addition to leaving the primary bar-
rier visible, the polyurethane film allows for savings of BRL 
55.48 when it is used as a secondary barrier in this case. The 
product indication is associated with different factors, such 
as scarring, resource availability, cost-benefit and PU char-
acteristics, but in this decision-making process, a trained 
professional makes all the difference(28). Health profession-
als’ knowledge and skill about indication and replacement 
frequency of barriers is essential for the choice of the most 
effective and economic treatment.
When compared to other dressings, those in which 
nanocrystalline silver and collagen and alginate were the 
most expensive, since barriers have higher costs, (BRL 
160.00 and BRL 129.00 respectively). However, the sec-
ondary barrier (hydrocolloid plate) was the main respon-
sible for the cost variation between dressings done with 
these two barriers. Both nanocrystalline silver and colla-
gen-alginate belong to different categories of barriers and 
mechanism of action when compared to the hydrocolloid. 
Therefore, for these two cases it would be useful to have a 
traditional secondary barrier (sterile gauze and micropore 
surgical tape). The hydrocolloid plate unit costs BRL 65.48, 
and the traditional secondary barrier costs between BRL 
1.12 and BRL 2.36. Once again, the choice of a more ap-
propriate secondary barrier would result in savings of BRL 
63.12 and BRL 64.36 respectively.
Comparing hydrocolloid and polyurethane film in this 
study, only the hydrocolloid was used as a primary barrier. 
However, a meta-analysis that compared these barriers 
showed that the polyurethane film is more likely to heal 
a PU(29).
Regarding the execution time of dressings, there was a 
variation of 5.75 to 33.73’ in the application of all barriers. 
When comparing sacral PU dressings with other PUs, it 
was observed that the time to position patients and clean 
sacral PUs was longer. Sacral PUs had longer minimum and 
maximum times when compared to other PUs. Probably 
due to the proximity to anal and genital regions, sacral PU 
dressings took longer, since they require more care to avoid 
contamination of the PU barrier and bed by intestinal and 
bladder evacuation.
The cost estimates do not reflect prices paid for pro-
cedures. They include costs involved in the procedure 
(dressing) of each PU according to the chosen approach. 
Nonetheless, it is believed that the study achieved the in-
tended goals and contributed to clinical practice, since the 
economic aspect is essential to decision making, both clini-
cally and collectively, considering the input availability.
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The use of economic grounds favors the rational use of 
resources and it is essential to the management of public 
health institutions in Brazil, considering that spendings on 
this field have been increasing, whereas resources available 
have not increased in the same proportion(17). Economic 
matters must be considered when choosing the most appro-
priate treatment for patients, since this may provide nurses 
with arguments regarding the cost needs of different bar-
riers, and allow them to decide together with the manage-
ment upon the allocation of resources for different activities.
CONCLUSION
Pressure ulcers are considered as a public health issue 
and they affect mainly hospitalized individuals, impairing 
patients’ safety. In addition, they result in high costs for the 
health system. Different barriers have costs that vary ac-
cording to the area and severity of PUs. This study allowed 
us to understand the costs involved in the treatment of PUs, 
and it may support decision makers and other cost-effec-
tiveness studies.
resUMO
Objetivo: Realizar uma avaliação do custo do tratamento tópico de pacientes com úlceras por pressão (UP), em uma unidade hospitalar 
de atendimento a pacientes crônicos no ano de 2014. Método: Trata-se de um estudo de custos baseado no Sistema de custeio Baseado 
em Atividades. Este método contempla a identificação, mensuração e precificação dos recursos físicos e humanos consumidos para a 
realização de curativos. Resultados: Os custos dos procedimentos variaram de R$16,41 a R$260,18. Para UP de mesma categoria, de 
áreas aproximadas e mesmo tipo de cobertura/adjuvante, a variação entre os custos foi de 3,5% a 614,6%. Para a maioria dos curativos, 
o custo aumentou proporcionalmente ao aumento da área e à progressão da categoria das UP. A cobertura primária representou elevado 
percentual nos custos entre todos os itens necessários para realizar os curativos (recursos humanos e materiais). Os curativos realizados 
nas UP sacrais foram os que apresentaram maiores tempos para execução. Conclusão: Este estudo permitiu conhecer os custos 
envolvidos no tratamento das UP e pode fornecer subsídios para os tomadores de decisão, assim como para a realização de estudos de 
custo-efetividade.
descritOres
Úlcera por Pressão; Sistema Único de Saúde; Custos Hospitalares; Terapêutica.
resUMen
Objetivo: Llevar a cabo una evaluación del costo del tratamiento tópico de pacientes con úlceras por presión (UP), en una unidad 
hospitalaria de atención a pacientes crónicos en el año de 2014. Método: Se trata de un estudio de costos basado en el Sistema de 
pago Basado en Actividades. Este método contempla la identificación, mensuración y precificación de los recursos físicos y humanos 
consumidos para la realización de apósitos. Resultados: Los costos de los procedimientos variaron de R$16,41 a R$260,18. Para UP de 
misma categoría, de áreas aproximadas y mismo tipo de cobertura/adyuvante, la variación entre los costos fue del 3,5% al 614,6%. Para la 
mayoría de los apósitos, el costo aumentó proporcionalmente al aumento del área y la progresión de la categoría de las UP. La cobertura 
primaria representó elevado porcentual en los costos entre todos los elementos necesarios para realizar los apósitos (recursos humanos 
y materiales). Los apósitos realizados en las UP sobre el sacro fueron los que presentaron mayores tiempos para ejecución. Conclusión: 
Este estudio permitió conocer los costos involucrados en el tratamiento de las UP y puede proporcionar subsidios para los tomadores de 
decisión, así como para la realización de estudios de costo-efectividad.
descriPtOres
Úlcera por Presión; Sistema Único de Salud; Costos de Hospital; Terapéutica.
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